Treasurer of the State of North Carolina’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$52.9M Buy
872,508
+18,588
+2% +$1.08M 0.17% 104
2025
Q4
$46.1M Sell
853,920
-62,391
-7% -$3M 0.15% 121
2025
Q3
$41.3M Sell
916,311
-35,702
-4% -$1.67M 0.13% 141
2025
Q2
$44.1M Buy
952,013
+23,364
+3% +$1.15M 0.14% 134
2025
Q1
$56.6M Sell
928,649
-121,659
-12% -$7.09M 0.23% 85
2024
Q4
$59.4M Sell
1,050,308
-15,910
-1% -$889K 0.23% 76
2024
Q3
$55.2M Buy
1,066,218
+10,400
+1% +$488K 0.22% 80
2024
Q2
$43.8M Sell
1,055,818
-15,850
-1% -$709K 0.19% 97
2024
Q1
$58.1M Buy
1,071,668
+13,830
+1% +$705K 0.26% 75
2023
Q4
$54.3M Sell
1,057,838
-4,996
-0.5% -$262K 0.26% 71
2023
Q3
$61.7M Buy
1,062,834
+16,071
+2% +$985K 0.33% 53
2023
Q2
$66.9M Buy
1,046,763
+21,738
+2% +$1.46M 0.35% 47
2023
Q1
$71M Buy
1,025,025
+19,202
+2% +$1.35M 0.4% 42
2022
Q4
$72.4M Buy
1,005,823
+42,629
+4% +$3.21M 0.44% 36
2022
Q3
$68.5M Buy
963,194
+8,970
+0.9% +$651K 0.45% 37
2022
Q2
$73.5M Sell
954,224
-6,463
-0.7% -$492K 0.46% 38
2022
Q1
$70.2M Sell
960,687
-20,230
-2% -$1.36M 0.39% 50
2021
Q4
$61.2M Buy
980,917
+5,140
+0.5% +$302K 0.32% 57
2021
Q3
$57.7M Buy
975,777
+2,520
+0.3% +$166K 0.33% 57
2021
Q2
$65M Sell
973,257
-19,110
-2% -$1.25M 0.38% 50
2021
Q1
$62.6M Buy
992,367
+3,210
+0.3% +$200K 0.39% 53
2020
Q4
$61.4M Buy
989,157
+4,130
+0.4% +$254K 0.41% 49
2020
Q3
$59.4M Buy
985,027
+3,490
+0.4% +$210K 0.45% 44
2020
Q2
$57.7M Sell
981,537
-181,250
-16% -$10.8M 0.48% 42
2020
Q1
$64.8M Buy
1,162,787
+81,420
+8% +$4.98M 0.58% 33
2019
Q4
$69.4M Buy
1,081,367
+329,377
+44% +$18.9M 0.58% 34
2019
Q3
$38.1M Sell
751,990
-308,240
-29% -$14.5M 0.34% 65
2019
Q2
$48.1M Sell
1,060,230
-8,660
-0.8% -$403K 0.3% 72
2019
Q1
$51M Buy
1,068,890
+3,917
+0.4% +$195K 0.33% 67
2018
Q4
$55.4M Buy
1,064,973
+12,035
+1% +$647K 0.4% 56
2018
Q3
$65.4M Buy
1,052,938
+379,083
+56% +$22.5M 0.41% 53
2018
Q2
$37.3M Buy
673,855
+418,037
+163% +$22.6M 0.39% 60
2018
Q1
$16.2M Buy
255,818
+251,116
+5,341% +$16.2M 0.42% 48
2017
Q4
$288K Buy
+4,702
New +$294K 0.71% 48

Other funds holding BMY

Treasurer of the State of North Carolina's BMY Position: Q1 2026 in Review

Treasurer of the State of North Carolina increased its Bristol-Myers Squibb (BMY) stake by 2.2% in Q1 2026, buying an estimated $1.08M and bringing the position to 872,508 shares worth $52.9M. The position accounts for 0.17% of the portfolio, ranked #104.

Treasurer of the State of North Carolina first reported a position in BMY in Q4 2017 and has held it in 34 quarters since. The position peaked at $73.5M in Q2 2022. 2,528 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Treasurer of the State of North Carolina held 872,508 shares of Bristol-Myers Squibb worth $52.9M as of Q1 2026.
  • Treasurer of the State of North Carolina bought 18,588 Bristol-Myers Squibb shares in Q1 2026, an estimated $1.08M.
  • Bristol-Myers Squibb made up 0.17% of Treasurer of the State of North Carolina's portfolio in Q1 2026, its #104 holding.
  • Treasurer of the State of North Carolina first reported a position in Bristol-Myers Squibb in Q4 2017 and has held it in 34 quarters since.
  • Treasurer of the State of North Carolina's Bristol-Myers Squibb position peaked at $73.5M in Q2 2022.
  • 2,528 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Treasurer of the State of North Carolina's 13F filing for Q1 2026, filed 14 May 2026.